[Effect of noradrenaline, glucagon and nicotinic acid on plasmatic levels of NEFA and glucose in dystrophic infants].
D001786:Blood Glucose / Q000032:analysis*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D005934:Glucagon / Q000627:therapeutic use*; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007223:Infant; D007228:Infant Nutrition Disorders / Q000378:metabolism*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009638:Norepinephrine / Q000627:therapeutic use*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D009539:Nicotinic Acids; D005934:Glucagon; D005947:Glucose; D009638:Norepinephrine
Effetto della noradrenalina, del glucagone e dell' acido nicotinico sulle concentrazioni plasmatiche dei NEFA e del glucosio in lattanti distrofici.